About Cell Therapies

Bev has over 20 years’ experience across the Australian and global biopharmaceutical & healthcare sectors. She holds a PhD in molecular medicine with additional qualifications in genetic counselling, project management and decision analysis.

Bev commenced her career with Postdoctoral roles in cancer research at Memorial Sloan Kettering Cancer Centre and the Peter MacCallum Cancer Centre, before moving to genetic counselling practice and then commercial roles in research & development, portfolio management and strategic partnerships in the pharmaceutical industry.

Dominic carries final product accountability under our licences, including those with the Therapeutic Goods Administration (TGA). As a co-founder of Cell Therapies, Dominic is an expert in CAR-T cell process development and analytics. He also has an appointment at the Peter MacCallum Cancer Centre, as Executive Director-Business Ventures, oversighting its Centres of Excellence in Cellular Immunotherapy, Theranostics, and Pathology.

Kate has 20 years of experience working in People and Culture roles across health, finance and professional services. She is passionate about supporting people to be their best at work and executes this through building strong relationships, understanding and alternative perspectives.

Bindhu leads our QA, QC and Validation teams, with overall responsibility for the QMS and GMP compliance at Cell Therapies. She has over 20 years of experience in the pharma industry and is a passionate supporter of embedding Quality and Continuous improvement.

Shri leads business development and strategic partnerships at Cell Therapies, driving client engagement, contract development, and cross-functional collaboration to support clinical and commercial manufacturing programs. With over 16 years of experience across biopharmaceutical business and process operations, GMP manufacturing, and CDMO strategy, he brings deep technical and commercial insight to the delivery of advanced therapies. His background includes leading CMC, process development, and regulatory programs for cell and gene therapies, with prior roles at Notch Therapeutics, Thermo Fisher Scientific, and Sun Pharma.

Deirdre experience includes Chief Operating Officer at Arts Centre Melbourne where her responsibilities include Finance, IT and digital, Facilities Management, Strategic Planning, Risk Management and more. Deirdre was on the Peter MacCallum Cancer Centre Board until July 2032, and is Chair of the Audit and Risk Management Committee.

Deirdre experience includes Chief Operating Officer at Arts Centre Melbourne where her responsibilities include Finance, IT and digital, Facilities Management, Strategic Planning, Risk Management and more. Deirdre was on the Peter MacCallum Cancer Centre Board until July 2032, and is Chair of the Audit and Risk Management Committee.

With over 20 years’ experience, Libby is a Finance professional with a demonstrated history of working in the financial services industry. She is skilled in operational leadership, Financial Risk, Internal Audit, Risk Management, and Corporate Finance. Before her successful career as a finance and accounting professional, Libby was a medical laboratory scientist at the Royal Children’s Hospital.